{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T11:12:27Z","timestamp":1725275547666},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fundaci\u00f3n Severo Ochoa-Aerom\u00e9dica Canaria and Ministerio de Ciencia, Investigaci\u00f3n e Innovaci\u00f3n, Spain","award":["SAF2016-77575-R","RD16-0060-0019"],"award-info":[{"award-number":["SAF2016-77575-R","RD16-0060-0019"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T01:00:51Z","timestamp":1558746051000},"page":"91-99","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Amidic derivatives of valproic acid, valpromide and valnoctamide, inhibit HSV-1 infection in oligodendrocytes"],"prefix":"10.1016","volume":"168","author":[{"given":"B.","family":"Praena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bello-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"L\u00f3pez-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.05.006_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/ppe.12064","article-title":"Antiherpetic medication use and the risk of gastroschisis: findings from the national birth defects prevention study, 1997-2007","volume":"27","author":"Ahrens","year":"2013","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089141","article-title":"The effect of cellular differentiation on HSV-1 infection of oligodendrocytic cells","volume":"9","author":"Bello-Morales","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.006_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147885","article-title":"Role of proteolipid protein in HSV-1 entry in oligodendrocytic cells","volume":"11","author":"Bello-Morales","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.006_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/13550280590924179","article-title":"High susceptibility of a human oligodendroglial cell line to herpes simplex type 1 infection","volume":"11","author":"Bello-Morales","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00088-18","article-title":"Role of microvesicles in the spread of herpes simplex virus 1 in oligodendrocytic cells","volume":"92","author":"Bello-Morales","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2165\/00003088-199120020-00003","article-title":"Clinical pharmacology of valpromide","volume":"20","author":"Bialer","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2019.05.006_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/epi.13634","article-title":"Progress report on new antiepileptic drugs: a summary of the thirteenth eilat conference on new antiepileptic drugs and devices (EILAT XIII)","volume":"58","author":"Bialer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.antiviral.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/bst0130075","article-title":"Valproic acid teratogenicity: demonstration that the biochemical mechanism differs from that of valproate hepatotoxicity","volume":"13","author":"Brown","year":"1985","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.antiviral.2019.05.006_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/jpet.114.218768","article-title":"Seizure control by derivatives of medium chain fatty acids associated with the ketogenic diet show novel branching-point structure for enhanced potency","volume":"352","author":"Chang","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.antiviral.2019.05.006_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2019.01.008","article-title":"In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: a systematic literature review","volume":"163","author":"Chemaly","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2016.01.009","article-title":"Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid","volume":"214","author":"Crespillo","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/JVI.56.2.558-570.1985","article-title":"Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4","volume":"56","author":"DeLuca","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1128\/JVI.72.9.7563-7568.1998","article-title":"Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid","volume":"72","author":"Desai","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jneumeth.2012.06.017","article-title":"Isolation of cortical mouse oligodendrocyte precursor cells","volume":"209","author":"Dincman","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.antiviral.2019.05.006_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12689","article-title":"Prevalence of herpes simplex virus types 1 and 2 at maternal and fetal sides of the placenta in asymptomatic pregnant women","volume":"78","author":"Finger-Jardim","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00406-017-0847-1","article-title":"Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort","volume":"268","author":"Fond","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.antiviral.2019.05.006_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virusres.2017.09.009","article-title":"Sodium phenylbutyrate abrogates African swine fever virus replication by disrupting the virus-induced hypoacetylation status of histone H3K9\/K14","volume":"242","author":"Frouco","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.05.006_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.antiviral.2019.05.006_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/v8110297","article-title":"The importance of physiologically relevant cell lines for studying virus-host interactions","volume":"8","author":"Hare","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.05.006_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/1673-5374.226380","article-title":"Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology","volume":"13","author":"Hogestyn","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.antiviral.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00019052-200304000-00014","article-title":"New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?","volume":"16","author":"Isoherranen","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijos.2016.3","article-title":"New strategies against drug resistance to herpes simplex virus","volume":"8","author":"Jiang","year":"2016","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.antiviral.2019.05.006_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1460-9568.1995.tb01115.x","article-title":"Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo","volume":"7","author":"Jung","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.antiviral.2019.05.006_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-8-481","article-title":"Herpes simplex virus infects most cell types in vitro: clues to its success","volume":"8","author":"Karasneh","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.05.006_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091912","article-title":"Mitochondrial liver toxicity of valproic acid and its acid derivatives is related to inhibition of \u03b1-lipoamide dehydrogenase","volume":"18","author":"Kudin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2019.05.006_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.1406","article-title":"Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice","author":"Lin","year":"2018","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.antiviral.2019.05.006_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072143","article-title":"A history of the pharmacological treatment of bipolar disorder","volume":"19","author":"Lopez-Munoz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2019.05.006_bib29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbabio.2007.06.007","article-title":"Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation","volume":"1767","author":"Luis","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl. 201","key":"10.1016\/j.antiviral.2019.05.006_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ane.12839","article-title":"Trials of antivirals in the treatment of multiple sclerosis","volume":"136","author":"Lycke","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.antiviral.2019.05.006_bib31","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00018-013-1340-2","article-title":"Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival","volume":"70","author":"Medina-Rodriguez","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2019.05.006_bib32","doi-asserted-by":"crossref","first-page":"43545","DOI":"10.1038\/srep43545","article-title":"Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis","volume":"7","author":"Medina-Rodriguez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.05.006_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pharmthera.2011.04.007","article-title":"Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives","volume":"131","author":"Mercorelli","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2019.05.006_bib34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/bdi.12220","article-title":"Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4","volume":"16","author":"Modi","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.antiviral.2019.05.006_bib35","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1172\/JCI80713","article-title":"Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma","volume":"125","author":"Nakashima","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2019.05.006_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2016.09.012","article-title":"Mood stabilizers inhibit cytomegalovirus infection","volume":"499","author":"Ornaghi","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.05.006_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03159976","article-title":"Characterization of a cell line derived from a human oligodendroglioma","volume":"16","author":"Post","year":"1992","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejphar.2018.03.006","article-title":"Valnoctamide: the effect on relieving of neuropathic pain and possible mechanisms","volume":"827","author":"Samur","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/epi.12480","article-title":"Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential","volume":"55","author":"Shekh-Ahmad","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.antiviral.2019.05.006_bib40","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1042\/BST0371126","article-title":"Structure-function studies for the panacea, valproic acid","volume":"37","author":"Terbach","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.antiviral.2019.05.006_bib41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1474-4422(15)00314-2","article-title":"Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib42","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.01717-10","article-title":"Inhibition of enveloped virus infection of cultured cells by valproic acid","volume":"85","author":"Vazquez-Calvo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib1a","author":"Vidal Vademecum Spain","year":"2018"},{"key":"10.1016\/j.antiviral.2019.05.006_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2006.04.002","article-title":"Herpes simplex encephalitis: adolescents and adults","volume":"71","author":"Whitley","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.05.006_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clp.2011.12.004","article-title":"The use of antiviral drugs during the neonatal period","volume":"39","author":"Whitley","year":"2012","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib45","first-page":"1704","article-title":"Herpes simplex virus infections of the central nervous system","volume":"21","author":"Whitley","year":"2015","journal-title":"Continuum"},{"key":"10.1016\/j.antiviral.2019.05.006_bib46","unstructured":"World Health Organization, Herpes Simplex Virus."},{"key":"10.1016\/j.antiviral.2019.05.006_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<201::AID-JMV5>3.0.CO;2-P","article-title":"Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes","volume":"61","author":"Wutzler","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.05.006_bib48","first-page":"1","article-title":"A resurging boom in new drugs for epilepsy and brain disorders","author":"Younus","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T17:57:44Z","timestamp":1608055064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219300671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":49,"alternative-id":["S0166354219300671"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amidic derivatives of valproic acid, valpromide and valnoctamide, inhibit HSV-1 infection in oligodendrocytes","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}